We recently studied the mutational landscape of 100 patients with MDS/MPN and found that men have a higher number of somatic mutations and higher frequency of mutations in the EZH2 gene independent of the specific disease sub-type (Karantanos et al., under review). Here, EZH2 is linked to myeloproliferative disorder.